Recent clinical trials of Novo Nordisk’s blockbuster GLP-1 drug semaglutide for Alzheimer’s disease may have failed to show ...

Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli ...

Dec 12 (Reuters) - The European Medicines ‌Agency's ​committee on Friday ‌recommended extending the use of Eli Lilly's ...

The pharmaceutical giant Eli Lilly has once again raised the bar in the highly competitive obesity treatment market. New clinical trial data for its experime ...

Current health news highlights U.S. senators urging action on a bird flu vaccine amid a poultry crisis, booming weight-loss drug markets, a significant IPO by Lumexa Imaging, and the impact of U.S.

Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a ...

FDA may expedite approval timeline for Eli Lilly's weight-loss treatment, potentially moving decision date to late March from ...

The European Medicines Agency's committee on Friday recommended extending ‍the use of Eli Lilly's blockbuster drug Mounjaro ...

Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli Lilly's experimental ...

The company also said earlier this week it will drop $6 billion on a new manufacturing facility in Huntsville, Alabama.

Donald Trump slammed Kamala Harris as a socialist on the campaign trail, writes Bruce Fein, but his nationalization of U.S.

A proposed new federal law could provide some competitive guardrails for the company's most important product.